...Bruno Roche; Didier Samuel Antiviral therapy using newer nucleos(t)ide analogues with lower resistance rates such as entecavir or tenofovir could suppress hepatitis B virus (HBV) replication, improve liver function, delay or obviate the need for liver transplantation in some patients, and reduce...

... report a case in which sustained viral response was achieved after switching treatment from pegylated interferon (PEG-IFN) α-2b to α-2a and ribavirin (RBV) in patients with recurrence of hepatitis C virus (HCV) infection after living donor liver transplantation. The patient was a 62-year-old man...

... in the HBV genome, possibly selected by immune pressure, can interfere with the export of viral proteins from hepatocytes and lead to direct virus-induced liver damage. Hepatitis B virus genome Immunopathogenesis Viral mutants Liver transplantation Chronic active hepatitis © 1993 S. Karger AG...

... carcinoma (HCC) who had undergone living-donor liver transplantation (LDLT). Materials and Methods: This institutional review board-approved prospective study was performed between February 12, 2003 and November 12, 2004; of the 78 candidates for LDLT due to HCC who underwent preoperative multidetector CT...

...Se Hyung Kim; Byung Ihn Choi; Jae Young Lee; Soo Jin Kim; Young Ho So; Hyo Won Eun; Jeong Min Lee; Joon Koo Han Liver transplantation has been considered to be the only causal treatment for liver cirrhosis patients with hepatocellular carcinoma (HCC) due to its theoretical advantage of eliminating...

... patients who undergo orthotopic liver transplantation are usually Child s class C, while only Child s class A or B patients can tolerate an extended hepatic resection. In addition, Asian pathologists recognized DN (formerly adenomatous hyperplasia) from hepatectomy specimens far earlier than the American...